Synthesis of N-Methylspiropyrrolidine Hybrids for Their Structural Characterization, Biological and Molecular Docking Studies

References

• J. Adrio, and J. C. Carretero, “Stereochemical Diversity in Pyrrolidine Synthesis by Catalytic Asymmetric 1,3-Dipolar Cycloaddition of Azomethine Ylides,” Chemical Communications (Cambridge, England) 55, no. 80 (2019): 11979–91.
   PubMedGoogle Scholar
• I. S. Young, J. L. Williams, and M. A. Kerr, “Diastereoselective Synthesis of Pyrrolidines Using a Nitrone/Cyclopropane Cycloaddition: Synthesis of the Tetracyclic Core of Nakadomarin A,” Organic Letters 7, no. 5 (2005): 953–5.
   PubMedGoogle Scholar
• G. Pandey, P. Banerjee, and S. R. Gadre, “Construction of Enantiopure Pyrrolidine Ring System via Asymmetric [3 + 2]-Cycloaddition of Azomethine Ylides,” Chemical Reviews 106, no. 11 (2006): 4484–17.
   PubMedGoogle Scholar
• A. Padwa, and W. H. Pearson, eds., Synthetic Applications of 1, 3-Dipolar Cycloaddition Chemistry toward Heterocycles and Natural Products, vol. 1 and 2 (New York: John Wiley & Sons, 2003).
   Google Scholar
• R. R. Kumar, S. Perumal, P. Senthilkumar, P. Yogeeswari, and D. Sriram, “Discovery of Antimycobacterial Spiro-Piperidin-4-Ones: An Atom Economic, Stereoselective Synthesis, and Biological Intervention,” Journal of Medicinal Chemistry 51, no. 18 (2008): 5731–5.
   PubMed Web of Science ®Google Scholar
• K. Lundahl, J. Schut, J. L. Schlatmann, G. B. Paerels, and A. Peters, “Synthesis and Antiviral Activities of Adamantane Spiro Compounds. 1. Adamantane and Analogous Spiro-3'-Pyrrolidines,” Journal of Medicinal Chemistry 15, no. 2 (1972): 129–32.
   PubMedGoogle Scholar
• S. Hati, S. Tripathy, P. K. Dutta, R. Agarwal, R. Srinivasan, A. Singh, S. Singh, and S. Sen, “Spiro[pyrrolidine-3, 3’-Oxindole] as Potent anti-Breast Cancer Compounds: Their Design, Synthesis, Biological Evaluation and Cellular Target Identification,” Scientific Report 6 (2016): 32213.
   PubMed Web of Science ®Google Scholar
• M. J. Kornet, and A. P. Thio, “Oxindole-3-Spiropyrrolidines and -Piperidines. Synthesis and Local Anesthetic Activity,” Journal of Medicinal Chemistry 19, no. 7 (1976): 892–8.
   PubMedGoogle Scholar
• M. Asad, M. N. Arshad, A. M. Asiri, S. A. Khan, M. Rehan, and M. Oves, “Synthesis, Characterization, Molecular Docking and Antimicrobial Activity of Novel Spiropyrrolidine Derivatives,” Polycyclic Aromatic Compounds (2021): 1–13. doi:10.1080/10406638.2021.1936083
   Google Scholar
• N. Arumugam, G. Periyasami, R. Raghunathan, S. Kamalraj, and J. Muthumary, “Synthesis and Antimicrobial Activity of Highly Functionalised Novel β-Lactam Grafted Spiropyrrolidines and Pyrrolizidines,” European Journal of Medicinal Chemistry 46, no. 2 (2011): 600–7.
   PubMedGoogle Scholar
• A. I. Almansour, N. Arumugam, R. Suresh Kumar, D. M. Al-Thamili, G. Periyasami, K. Ponmurugan, N. A. Al-Dhabi, K. Perumal, and D. Premnath, “Domino Multicomponent Approach for the Synthesis of Functionalized Spiro-Indeno[1,2-b]Quinoxaline Heterocyclic Hybrids and Their Antimicrobial Activity: Synergistic Effect and Molecular Docking Simulation,” Molecules 24, no. 10 (2019): 1962.
   PubMedGoogle Scholar
• M. Rehan, “An Anti-Cancer Drug Candidate OSI-027 and its Analog as Inhibitors of mTOR: Computational Insights into the Inhibitory Mechanisms,” Journal of Cellular Biochemistry 118, no. 12 (2017): 4558–67.
   PubMed Web of Science ®Google Scholar
• M. Rehan, and O. S. Bajouh, “Virtual Screening of Naphthoquinone Analogs for Potent Inhibitors against Cancer-Signaling PI3K/AKT/mTOR Pathway,” Journal of Cellular Biochemistry 120, no. 2 (2019): 1328–39.
   PubMed Web of Science ®Google Scholar
• M. Rehan, “Anticancer Compound XL765 as PI3K/mTOR Dual Inhibitor: A Structural Insight into the Inhibitory Mechanism Using Computational Approaches,” PLoS ONE 14, no. 6 (2019): e0219180.
   PubMed Web of Science ®Google Scholar
• M. Rehan, M. M. Mahmoud, S. Tabrez, H. M. A. Hassan, and G. M. Ashraf, “Exploring Flavonoids for Potential Inhibitors of a Cancer Signaling Protein PI3Kγ Kinase Using Computational Methods,” Anticancer Research 40, no. 8 (2020): 4547–56.
   PubMed Web of Science ®Google Scholar
• F. Collin, S. Karkare, and A. Maxwell, “Exploiting Bacterial DNA Gyrase as a Drug Target: Current State and Perspectives,” Applied Microbiology and Biotechnology 92, no. 3 (2011): 479–97.
   PubMed Web of Science ®Google Scholar
• Agilent CrysAlis PRO, Agilent Technologies, Yarnton, England, 2012.
   Google Scholar
• G. M. Sheldrick, “Crystal Structure Refinement with SHELXL,” Acta Crystallographica. Section C, Structural Chemistry 71, no. Pt 1 (2015): 3–8.
   PubMed Web of Science ®Google Scholar
• A. L. Spek, “PLATON-a Multipurpose Crystallographic Tool,” (Utrecht University, Utrecht, 2005).
   Google Scholar
• L. J. Farrugia, “Win GX and ORTEP for Windows,” Journal of Applied Crystallography 45, no. 4 (2012): 849–54.
   Web of Science ®Google Scholar
• L. J. Farrugia, “WinGX Suite for Small-Molecule Single-Crystal Crystallography,” Journal of Applied Crystallography 32, no. 4 (1999): 837–8.
   Google Scholar
• J. M. Andrews, “Determination of Minimum Inhibitory Concentrations,” Journal of Antimicrobial Chemotherapy 48, no. suppl_1 (2001): 5–16.
   PubMed Web of Science ®Google Scholar
• N. M. O. Boyle, M. Banck, C. A. James, C. Morley, T. Vandermeersch, and G. R. Hutchison, “Open Babel: An Open Chemical Toolbox,” Journal of Cheminformatics 3 (2011): 33.
   PubMed Web of Science ®Google Scholar
• T. J. Ewing, S. Makino, A. G. Skillman, and I. D. Kuntz, “DOCK 4.0: Search Strategies for Automated Molecular Docking of Flexible Molecule Databases,” Journal of Computer-Aided Molecular Design 15, no. 5 (2001): 411–28.
   PubMed Web of Science ®Google Scholar
• E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. C. Meng, and T. E. Ferrin, “UCSF Chimera-A Visualization System for Exploratory Research and Analysis,” Journal of Computational Chemistry 25, no. 13 (2004): 1605–12.
   PubMed Web of Science ®Google Scholar
• R. A. Laskowski, and M. B. Swindells, “LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery,” Journal of Chemical Information and Modeling 51, no. 10 (2011): 2778–86.
   PubMed Web of Science ®Google Scholar
• The PyMOL Molecular Graphics System, Version 2.4.0 Schrödinger, LLC.
   Google Scholar
• R. Wang, L. Lai, and S. Wang, “Further Development and Validation of Empirical Scoring Functions for Structure-Based Binding Affinity Prediction,” Journal of Computer-Aided Molecular Design 16, no. 1 (2002): 11–26.
   PubMed Web of Science ®Google Scholar
• Y. Sarrafi, M. Hamzehloueian, K. Alimohammadi, and S. Yeganegi, “Experimental and Theoretical Approaches to [1,5]-Prototropic Generation of an Azomethine Ylide and a 1,3-Dipolar Cycloaddition for Novel Spiropyrrolidine Oxindoles Synthesis,” Journal of Molecular Structure 1030 (2012): 168–76.
   Google Scholar
• S. A. Khan, A. M. Asiri, K. A. Alamry, S. A. El-Daly, and M. A. M. Zayed, “Eco-Friendly Synthesis and in Vitro Antibacterial Activities of Some Novel Chalcones,” Russian Journal of Bioorganic Chemistry 39, no. 3 (2013): 312–7.
   Google Scholar
• S. A. Khan, and A. M. Asiri, “Green Synthesis, Characterization and Biological Evaluation of Novel Chalcones as anti Bacterial Agents,” Arabian Journal of Chemistry 10 (2017): S2890–S95.
   Web of Science ®Google Scholar
• G. Vanangamudi, M. Subramanian, and G. Thirunarayanan, “Synthesis, Spectral Linearity, Antimicrobial, Antioxidant and Insect Antifeedant Activities of Some 2,5- Dimethyl-3-Thienyl Chalcones,” Arabian Journal of Chemistry 10 (2017): S1254–S66.
   Web of Science ®Google Scholar
• T. Christophe, H. Michelyne, X. Iakovos, L. Konstantinos, T. Evangelia, E. Phaedra, P. Anthi, A. Bandar, A. Mahesh, V. K. N. H. Sree, et al, “Design, Synthesis, Evaluation of Antimicrobial Activity and Docking Studies of New Thiazole-Based Chalcones,” Current Topics in Medicinal Chemistry 19, no. 5 (2019): 356–75.
   PubMedGoogle Scholar